Corcept Therapeutics Aktie
56,08
EUR
-4,60
EUR
-7,58
%
68,69
USD
+1,64
USD
+2,45
%
Werbung
Corcept Therapeutics Aktie Analyse
10.08.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
31.05.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
09.03.18 | Corcept Therapeutics Buy | B. Riley FBR, Inc. | |
31.08.17 | Corcept Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
21.04.15 | Corcept Therapeutics Outperform | FBR Capital | |
02.11.09 | Corcept Therapeutics kaufen | Global Biotech Investing | |
15.08.05 | Corcept Therapeutics Buy | Punk, Ziegel & Co | |
25.04.05 | Corcept Therapeutics Outperform | Harris Nesbitt | |
Werbung
|
Werbung
Werbung